[Evaluation of the new therapy in the treatment of shock. Use of the beta adrenergic metaproterenol].
D000328:Adult; D000368:Aged; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001794:Blood Pressure / Q000187:drug effects; D001831:Body Temperature / Q000187:drug effects; D004231:Diuresis / Q000187:drug effects; D004983:Ethanolamines / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011674:Pulse / Q000187:drug effects; D012769:Shock / Q000188:drug therapy*
D000889:Anti-Arrhythmia Agents; D004983:Ethanolamines
Evaluación de la nueva terapia en el tratamiento del shock. Uso del beta adrenérgico metaproterenol